20xx年醫(yī)學(xué)專(zhuān)題—糖尿病與發(fā)炎指標(biāo)crp(編輯修改稿)
2024-11-14 01:45 本頁(yè)面
【文章內(nèi)容簡(jiǎn)介】 p = 0.772), respectively. Conclusion: Median CRP remained stable with pravastatin and cerivastatin use, although TC and LDL decreased. The further decline observed with LDL, but not CRP suggests differing effects of statins on LDL and CRP.,Shinn AH, et al Curr Med Res Opin. 2005。 (2): 207213.,第十頁(yè)，共二十六頁(yè)。,Risk Factors for CHD,Modifiable Hypertension High LDL cholesterol Low HDL cholesterol Cigarette smoking Physical inactivity Diabetes Obesity (BMI 30) Thrombogenic/hemostatic state Atherogenic diet,Nonmodifiable Age Male sex Family history of premature CHD,National Cholesterol Education Program Adult Treatment Panel III. 2002. NIH Publication No. 025215.,第十一頁(yè)，共二十六頁(yè)。,Factors Associated with Increased or Decreased CRP,Higher CRP Hypertension Hyperglycemia Low HDL/ high TG Smoking Obesity Metabolic syndrome Estrogen/progesterone use Chronic infection,Lower CRP Increase exercise Alcohol consumption Weight loss Medication: Statin Fibrate,第十二頁(yè)，共二十六頁(yè)。,Hypertension and Dyslipidaemia Are Major Risk Factors for CHD,Kannel W. In: Hypertension: Pathophysiology and Treatment. New York: McGrawHill, Inc.。 1977:888909。 Castelli WP. Am J Med. 1984。76:412.,CHD incidence/1000,Probability of CVD/1000,Age,40,50,60,70,Framingham study,SBP (mm Hg) in men,TC (mg/dL) in men,第十三頁(yè)，共二十六頁(yè)。,Concomitant Hypertension and Dyslipidemia Increase the Risk of Developing Fatal CVD,Adapted from De Backer G et al. Eur J Cardiovasc Prev Rehabil. 2003。10 (suppl 1):S1S78.,Dyslipidemia,Hypertension,Dyslipidemia/ Hypertension,TC 271 mg/dL (7 mmol/L),SBP 180 mm Hg,TC 271 mg/dL (7 mmol/L) SBP 180 mm Hg,第十四頁(yè)，共二十六頁(yè)。,Hypertension and High Cholesterol are Twice as Prevalent in Adults with DM Compared to those without DM,Archives of Internal Medicine 200
合同協(xié)議相關(guān)推薦
鄂ICP備17016276號(hào)-1